Search results
If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance UK· 7 hours agoAnother thing that can drive investing is the fear of missing out, or FOMO. This particularly...
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance UK· 7 hours agoEli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal
Reuters via Yahoo Finance UK· 13 hours ago(Reuters) -Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on...
Billionaire Harvard Professor’s Fortune Jumps Nearly $200 Million On News Of Eli Lilly Biotech Deal
Forbes· 18 hours agoNow, he’s set to receive a nine-digit windfall from pharma giantEli Lilly’s $3.2 billion acquisition...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Finance UK· 14 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Here's Why Eli Lilly (LLY) is a Strong Momentum Stock
Zacks via Yahoo Finance UK· 7 hours agoEmploying factors like one-week price change and the monthly percentage change in earnings...
A weight loss miracle! New shot does better than Ozempic and Wegovy during trials
The Independent· 2 hours agoTirzepatide, which is sold under the brand names Mounjaro and Zepbound – which treat diabetes and...
Lilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal
Bloomberg via Yahoo Finance UK· 8 hours ago(Bloomberg) -- Eli Lilly & Co. agreed to buy U.S. gut-drug maker Morphic Holding Inc. for about $3.2...
FDA approves Eli Lilly's treatment which slows symptoms down
Daily Mail· 6 days agoThe US FDA has approved donanemab, a treatment for Alzheimer's disease that helps the body remove...
FDA approves second Alzheimer’s drug that can modestly slow disease
Express and Star· 6 days agoThe Food and Drug Administration (FDA) approved Eli Lilly’s Kisunla, known chemically as donanemab,...